MedLink International Inc(MLKNA)
USD --+0.00%
Reward71High
Risk42Moderate
📊75%Data
Thin 3% profit margin
MLKNA
+0.0 · +0.00%
USD · OTCCE
MedLink International Inc | Healthcare
Quality Compounder
Market Cap:4759
ℹ️
Reward Rating
71
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
42
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MLKNA to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is MedLink International Inc?

engages in selling, implementing, and supporting software solutions that provide physician practices, laboratories, and other healthcare organizations access to clinical, administrative, and financial data.

MLKNA · Verdict

Strong reward · moderate risk

MLKNA stands out on growth and balance sheet, but watch the cash flow signal.

Based on 88% data coverage

MLKNA · Verdict

What’s working & what to watch

Strengths 3

  • Growth92/100

    Revenue +177.7% CAGR

  • Balance sheet75/100

    Current ratio 1.05

  • Volatility75/100

    Above average

Watchouts 1

  • Cash flow37/100

    3% net margin

Model-based scoring. For information only — not financial advice.

What is MedLink International Inc?

engages in selling, implementing, and supporting software solutions that provide physician practices, laboratories, and other healthcare organizations access to clinical, administrative, and financial data. The company offers MedLink iSuite EHR that automates physician activities, such as prescribing, dictating, ordering lab tests and viewing results, documenting clinical encounters, and capturing charges, among others; and MedLink IX (Information eXchange), an enterprise connectivity solution that links providers and healthcare services to achieve interoperability deployed in commercial and hospital laboratories. The company is listed on the OTCCE in USA, operating in the Healthcare sector, with a market capitalisation of 4.76K.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: High (71)

The scoring profile indicates a strong reward potential, driven primarily by growth and profitability. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap4.76K
P/E Ratio0.01
Dividend YieldN/A
52 Week High0.0001
52 Week Low0.0001
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding42M
No. of EmployeesN/A
IndustryMedical Care Facilities
ExchangeOTCCE
Beta-51.868
CurrencyUSD